Clinical Trials Embrace AI, Real-World Data Integration, and Digital Protocol Transformation
Industry leaders highlight advances in AI-enabled trial monitoring, real-world data interoperability, and protocol-driven eSource systems, while emphasizing the need for community engagement in diversity efforts and addressing operational risks in rare disease trials.